Atlas Trials

Stage II Non-Small Cell Lung Cancer

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage II Non-Small Cell Lung Cancer

RecordFirmDate
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery (NCT03433469)University of California, San Francisco2018-07-31
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer (NCT03366766)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2017-12-20
TG4010 and Nivolumab in Patients With Lung Cancer (NCT02823990)Megan Daly, MD2016-12-14
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer (NCT02621398)Rutgers, The State University of New Jersey2016-08-04
Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma (NCT02319889)Case Comprehensive Cancer Center2016-02-02
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191)National Cancer Institute (NCI)2004-05-01
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer (NCT00019006)National Cancer Institute (NCI)1995-03-01

Track Stage II Non-Small Cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.